Organisms | Evidence |
---|---|
Fasciola hepatica (liver fluke) | |
Echinococcus granulosus | |
Rattus norvegicus (Norway rat) | |
Armadillo | |
Severe acute respiratory syndrome coronavirus 2 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
O00267 | Transcription elongation factor SPT5 | ||
O00339 | Matrilin-2 | ||
O00391 | Sulfhydryl oxidase 1 | ||
O00451 | GDNF family receptor alpha-2 | ||
O00461 | Golgi integral membrane protein 4 | ||
O00468 | Agrin | ||
O00567 | Nucleolar protein 56 | ||
O00592 | Podocalyxin | ||
O14511 | Pro-neuregulin-2, membrane-bound isoform | ||
O14657 | Torsin-1B |
Pathway Name | Organism |
---|---|
E.coli O101 | Escherichia coli |
E.coli O103 | Escherichia coli |
E.coli O107 | Escherichia coli |
E.coli O112ab | Escherichia coli |
E.coli O112ac | Escherichia coli |
E.coli O116 | Escherichia coli |
E.coli O117 | Escherichia coli |
E.coli O125ab | Escherichia coli |
E.coli O127 | Escherichia coli |
E.coli O128ab-H27 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
31404475 | The Plasticity of the Carbohydrate Recognition Domain Dictates the Exquisite Mechanism of Binding of Human Macrophage Galactose‐Type Lectin | Diniz A | 2019 Nov 04 |
|
31144994 | Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides | Wang Y | 2019 May 30 |
|
31039049 | Current and emerging biologics for the treatment of hemophilia | Castaman G | 2019 May 09 |
|
30843692 | Redox-Controlled Site-Specific α2–6-Sialylation | Lu N | 2019 Mar 07 |
|
30820542 | Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates | Janas MM | 2019 Mar 01 |
|
30824758 | Glycosylation of Staphylococcus aureus cell wall teichoic acid is influenced by environmental conditions | Mistretta N | 2019 Mar 01 |
|
30591584 | Biosynthesis of O-N-acetylgalactosamine glycans in the human cell nucleus | Cejas RB | 2019 Mar 01 |
|
30500509 | Chondroitin sulfate isolated from the secretion of the venom-producing parotoid gland of Brazilian bufonid | da Silva HAM | 2019 Mar 01 |
|
31029427 | Identification of the O-GalNAcylation site(s) on FOXA1 catalyzed by ppGalNAc-T2 enzyme in vitro | Zhang S | 2019 Jun 18 |
|
31005367 | Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR) | Zhang Y | 2019 Jun 01 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025